The new cancer therapy system will be used by Baptist Health South Florida to offer neurosurgical care, including diagnosis and treatment of brain disorders and tumours
ZAP-X Gyroscopic Radiosurgery platform for advanced brain tumour treatments (Credit: Business Wire/ ZAP Surgical Systems, Inc.)
Baptist Health South Florida is set to acquire the ZAP-X Gyroscopic Radiosurgery platform from medical equipment maker ZAP Surgical Systems.
Baptist Health intends to use the platform for cranial stereotactic radiosurgery (SRS) and in the advancement of brain tumour treatments.
Miami Neuroscience Institute and Miami Cancer Institute, both part of Baptist Health South Florida, will use the platform to diagnose and treat brain disorders and tumours.
The installation of the ZAP-X Gyroscopic Radiosurgery platform is expected to commence later this year.
According to ZAP Surgical, the ZAP-X has a unique gyroscopic design that can deliver several angled radiation beams precisely sculpted to the contours of targeted lesions.
The platform can improve patient outcomes by enhancing the ability to avoid critical parts like the brain stem, eyes, and optic nerves, while also lowering healthy brain tissue exposure to preserve patient cognitive function.
Miami Neuroscience Institute chief medical executive Michael McDermott said: “When treating the brain, particularly with a procedure as complex as radiosurgery, the technology and precision must be exquisite.
“ZAP-X is the latest advance in SRS, and the first new dedicated radiosurgery technology platform in over 30 years. This innovation enables our centre to offer patients the highest level of care.”
The platform is claimed to be the first and only vault-free SRS delivery system that avoids the need for costly shielded radiation treatment rooms.
The firm said that the ZAP-X uses a linear accelerator to produce radiation without the requirement of Cobalt-60 radioactive sources.
Miami Cancer Institute chief of radiation oncology Dr Minesh Mehta said: “Miami Cancer Institute is in the unique position of having access to virtually every radiation delivery technology available.
“This allows our team to align each patient with a tailored therapy and technology for highly individualised indications and needs. We look forward to ZAP-X further complementing our portfolio of therapeutic solutions.”
Initially, ZAP-X will be housed in a temporary facility to allow for quick installation before moving to the new Miami Neuroscience Institute building on Baptist Health South Florida’s Dadeland campus.